Skip to main content
Industry News
MilliporeSigma, ReForm: New licensing deal for excipients
2/14/2020

MilliporeSigma and ReForm Biologic have entered into a global licensing deal that will advance research and development of excipients to manufacture biologics, including qualification activities prior to their commercialization.

Full Story: